Boston Scientific Corporation vs Atlassian Corporation PLC — how do they compare? Boston Scientific Corporation trades at $51.07 (market cap $74.19B), while Atlassian Corporation PLC trades at $152.51 (market cap $39.10B). The key difference: Boston Scientific Corporation is the larger of the two by market cap, and Atlassian Corporation PLC is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | TEAM | |
|---|---|---|
Market Cap | $74.19B | $39.10B |
Sector | Health | Technology |
52-Week High | $108.14 | $182.36 |
52-Week Low | $42.63 | $57.15 |
Enterprise Value | $86.27B | $39.09B |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Read more on TEAM →